piribedil has been researched along with Buerger Disease in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guagliano, G | 1 |
| Bagliani, A | 1 |
| Borri, P | 1 |
1 trial available for piribedil and Buerger Disease
| Article | Year |
|---|---|
[Therapeutic acquisitions on chronic obliterating peripheral arterial diseases of the lower limbs].
Topics: Arteriosclerosis Obliterans; Chronic Disease; Clinical Trials as Topic; Humans; Leg; Piribedil; Thro | 1976 |